• 1 year ago
New malaria drug brings hope for infants in Uganda

Swiss regulators have approved the first malaria treatment safe for infants. The new drug, known as Coartem Baby or Riamet Baby, is specifically formulated for newborns and infants under five kilograms, an age group previously left out of treatment plans.

READ MORE : http://www.africanews.com/2025/08/20/new-malaria-drug-brings-hope-for-infants-in-uganda

Subscribe on our Dailymotion channel and receive all the latest news from the continent.

Africanews is available in English and French.
Website : www.africanews.com
Facebook : https://www.facebook.com/africanews.channel/
Twitter : https://twitter.com/africanews

Category

🗞
News
Transcript
00:00Fresh hope for babies born with malaria as the first vaccine safe for infants gets the green light from Swiss regulators.
00:09It's a potential game changer, especially here in Uganda, where over 12 million cases and nearly 16,000 deaths were recorded in 2023.
00:18Until now, the vaccines available were only suitable for older children, making administering them to babies a medical minefield.
00:25We are beginning to get children below six months coming in with malaria.
00:34Some are born with malaria, and that is what we refer to as congenital malaria.
00:39Some come in with infections during the neonatal period, that's below one month.
00:49And the treatment has been quite challenging, because we are giving them the dose that is given to those that are 5 kilograms to 14 kilograms,
01:02which was a bit challenging, because the key question was, was that the right amount for their kind of kilograms?
01:12Because normally those children are below 5 kilograms.
01:15Like the newborns, most of them will be between 2.5 to 4.5.
01:20The newly approved drug, known as Cortem Baby or ReaMet Baby, combines two anti-malarials tailored for infants.
01:30Accurate dosing is critical as mistakes not only risk overdose, but also feel dangerous resistance.
01:36Now that we have this new medicine, we are going to be able to respond to our needs, to our gap.
01:43Otherwise, before the risk was that, when you're not giving accurate treatments, we are seeing the rise of anti-malarial resistance.
01:51That means that the malaria drugs are not working, as they should, because of things like the dosages not being accurate for babies.
01:59Malaria remains the leading cause of illness and death in children under five, including newborns in Uganda.
02:05The new infant-friendly drug will be rolled out in Uganda and seven other countries across Africa, including Burkina Faso and Nigeria.

Recommended